MedTrace Logo

Atorvastatin and Clopidogrel HIgh DOse in Stable Patients With Residual High Platelet Activity

NCT01335048 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2012-01-26

No results posted yet for this study

Summary

The purpose of this study is to evaluate if high-dose (80mg/day) atorvastatin might exert an adjunctive anti-platelet effect compared to high-dose clopidogrel (150mg/day) in stable patients with high on-treatment reactivity according to a point-of-care platelet function assay.

Conditions

  • Stable Angina

Interventions

DRUG

atorvastatin and clopidogrel

Atorvastatin 80 mg daily + clopidogrel 150 mg daily

DRUG

Clopidogrel

Clopidogrel 150 mg daily

Sponsors & Collaborators

  • Ospedale Misericordia e Dolce

    lead OTHER

Principal Investigators

  • Mario Leoncini, MD · Ospedale Misericordia e Dolce, Prato

  • Anna Toso, MD · Ospedale Misericordia e Dolce, Prato

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2012-01-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01335048 on ClinicalTrials.gov